Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population
![]() |
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT03119675 |
Recruitment Status :
Completed
First Posted : April 18, 2017
Last Update Posted : March 13, 2018
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
Objective: Prospective evaluation of GoCheckKids™, a smartphone application ('App') as a photo screening device in a pediatric population to detect amblyopia risk factors (ARFs)
Method: Photorefraction images are captured using up to 4 different devices with GoCheckKids™ App and patients are evaluated with cycloplegic refraction.
Condition or disease | Intervention/treatment | Phase |
---|---|---|
Amblyopia | Device: GoCheck Kids (iOS) Device: GoCheck Kids (Windows) | Not Applicable |
Study Type : | Interventional (Clinical Trial) |
Actual Enrollment : | 358 participants |
Allocation: | N/A |
Intervention Model: | Single Group Assignment |
Masking: | None (Open Label) |
Primary Purpose: | Screening |
Official Title: | Prospective Evaluation of a Smartphone Application, GoCheckKids™ as a Photo Screening Tool in a Pediatric Population |
Actual Study Start Date : | November 2016 |
Actual Primary Completion Date : | March 2017 |
Actual Study Completion Date : | May 2017 |
Arm | Intervention/treatment |
---|---|
Photorefraction of ages 1 to 6 years
Clinical Validation of GoCheck Kids Smartphone App
|
Device: GoCheck Kids (iOS)
Photorefraction method is used to screen amblyopia risk factors. Device: GoCheck Kids (Windows) Photorefraction method is used to screen amblyopia risk factors. |
- Sensitivity and specificity of amblyopia risk factors detected by photo refraction [ Time Frame: 1 Day ]Identification of risk factors as compared to gold standard cycloplegic refraction
- Number of patients with gaze error identified by photo screening [ Time Frame: 1 day ]Detection of gaze error compared to cover test examination results

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
Ages Eligible for Study: | 1 Year to 6 Years (Child) |
Sexes Eligible for Study: | All |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- Age 12 months to 6 years inclusive.
- Informed consent given by parent or legal guardian.
Exclusion Criteria:
- History of ocular surgery and any condition that would preclude the ability of the investigator to obtain a reliable image and measurement

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT03119675
Principal Investigator: | Sean Donahue, MD, PhD | Vanderbilt University |
Responsible Party: | Gobiquity Mobile Health |
ClinicalTrials.gov Identifier: | NCT03119675 |
Other Study ID Numbers: |
2016-001 |
First Posted: | April 18, 2017 Key Record Dates |
Last Update Posted: | March 13, 2018 |
Last Verified: | March 2018 |
Studies a U.S. FDA-regulated Drug Product: | No |
Studies a U.S. FDA-regulated Device Product: | No |
Myopia Hyperopia Anisometropia Amblyopia Risk Factors Risk Factors |
Smartphone Application (App) Photoscreening Vision Screening Mobile Vision Screening |
Amblyopia Brain Diseases Central Nervous System Diseases Nervous System Diseases |
Vision Disorders Sensation Disorders Neurologic Manifestations Eye Diseases |